Hendershot Investments Inc. Has $25.76 Million Holdings in Johnson & Johnson (NYSE:JNJ)

Hendershot Investments Inc. increased its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 155,351 shares of the company's stock after purchasing an additional 5,615 shares during the period. Johnson & Johnson makes up about 3.5% of Hendershot Investments Inc.'s portfolio, making the stock its 6th biggest holding. Hendershot Investments Inc.'s holdings in Johnson & Johnson were worth $25,763,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. WealthTrak Capital Management LLC acquired a new stake in shares of Johnson & Johnson during the 4th quarter valued at $26,000. Conquis Financial LLC acquired a new stake in shares of Johnson & Johnson during the 4th quarter valued at $33,000. Bernard Wealth Management Corp. acquired a new stake in shares of Johnson & Johnson during the 4th quarter valued at $36,000. Highline Wealth Partners LLC boosted its holdings in shares of Johnson & Johnson by 51.8% during the 1st quarter. Highline Wealth Partners LLC now owns 252 shares of the company's stock valued at $42,000 after acquiring an additional 86 shares in the last quarter. Finally, von Borstel & Associates Inc. acquired a new position in Johnson & Johnson during the 1st quarter worth about $49,000. 69.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. UBS Group reaffirmed a "buy" rating and set a $190.00 target price (up from $180.00) on shares of Johnson & Johnson in a report on Thursday, July 17th. Piper Sandler reaffirmed an "overweight" rating on shares of Johnson & Johnson in a report on Thursday, July 17th. Sanford C. Bernstein reissued a "market perform" rating on shares of Johnson & Johnson in a research note on Wednesday, April 16th. Bank of America boosted their price objective on Johnson & Johnson from $161.00 to $175.00 and gave the company a "neutral" rating in a research note on Thursday, July 17th. Finally, Barclays boosted their price objective on Johnson & Johnson from $165.00 to $176.00 and gave the company an "equal weight" rating in a research note on Thursday, July 17th. Nine analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Johnson & Johnson has an average rating of "Moderate Buy" and an average target price of $174.50.

Johnson & Johnson Trading Up 0.3%

NYSE:JNJ traded up $0.52 during mid-day trading on Thursday, reaching $169.62. 6,629,361 shares of the company's stock traded hands, compared to its average volume of 8,401,730. Johnson & Johnson has a 12-month low of $140.68 and a 12-month high of $169.99. The firm has a market capitalization of $408.11 billion, a price-to-earnings ratio of 18.14, a PEG ratio of 2.15 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.26 and a quick ratio of 1.03. The company has a 50 day moving average price of $155.75 and a 200-day moving average price of $155.63.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last announced its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.68 by $0.09. Johnson & Johnson had a return on equity of 33.07% and a net margin of 25.00%. The company had revenue of $23.74 billion for the quarter, compared to the consensus estimate of $22.85 billion. During the same quarter in the previous year, the business earned $2.82 EPS. Johnson & Johnson's revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, August 26th. This represents a $5.20 annualized dividend and a yield of 3.07%. Johnson & Johnson's payout ratio is 55.61%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.